Concurrent Session 6A: Abstract Session. HCV Innovations
Tracks
Track 1
| Friday, October 9, 2026 |
| 11:45 AM - 1:15 PM |
| Zenit |
Speaker
INHSU 2026
Welcome & Introduction
11:45 AM - 11:50 AMBiography
Madeline Mccrary
Assistant Professor Of Medicine
Washington University School Of Medicine
Hepatitis C antenatal linkage-to-care (HALT-C) bundle is associated with improved outcomes compared to usual postpartum care
11:50 AM - 12:05 PMBiography
Madeline McCrary is an infectious diseases and addiction medicine physician at Washington University in St. Louis, Missouri. Her clinical and research focus is on developing and implementing novel models of care to expand access to Hepatitis C treatment, particularly for people who use drugs, in spaces where there is already engagement in healthcare for other reasons - the hospital and prenatal care.
A/Prof Marianne Martinello
Associate Professor / ID Physician
Kirby Institute / Prince Of Wales Hospital
STRIVE4: sofosbuvir plus glecaprevir-pibrentasvir for four weeks among people with HCV infection and early liver disease
12:05 PM - 12:20 PMBiography
A/Prof Marianne Martinello is an infectious diseases physician, deputy program head and NHMRC Emerging Leadership Fellow at the Kirby Institute, UNSW and Prince of Wales Hospital, Sydney.
Dr. David Goodman-Meza
Senior Research Associate
Unsw
Is universal fibrosis screening necessary before DAA therapy? A decision curve analysis of age-based strategies
12:20 PM - 12:35 PMBiography
David Goodman-Meza is a Senior Research Associate in the Kirby Institute, UNSW Sydney since 2024. He is a clinician-scientist with expertise in Infectious Diseases and Substance Use Disorders. He has expertise in using methods from artificial intelligence to evaluate clinical outcomes in electronic health records, as well as experience in conducting clinical trials.
Dr Huei-Jiuan Wu
Post-doctoral Research Fellow
Unsw/ Kirby Institute
Impact and cost-effectiveness of scaling up a national point-of-care hepatitis C testing and treatment program in Australia: A mathematical modelling study
12:35 PM - 12:50 PMBiography
Joyce is currently working as a postdoctoral fellow at the Kirby Institute, where she continues to work on integrating innovative testing strategies with person-centred services to inform policy and support hepatitis C elimination efforts.
Dr Hunter Spencer
Associate Professor
Oregon Health & Science University
Dried Blood Spot Test-and-Treat (DBS TaT) in Peer-Assisted Telemedicine for Hepatitis C: A Cluster Randomized Controlled Trial
12:50 PM - 12:55 PMBiography
Dr. Spencer, DO, MCR is Associate Professor of Medicine at Oregon Health & Science University and practices general internal medicine, HIV medicine, and addiction medicine. He is a clinician-scientist focused on improving access to HIV prevention and hepatitis C treatment for rural people who use drugs. He leads Peer-Assisted Telemedicine for Health in Substance Users (PATHS), a new way for people who use drugs to access healthcare throughout Oregon.
Ms Tracey Brown
Service Director, Population Health
Justice Health And Forensic Mental Health Network
Scale-up of hepatitis C point-of-care testing and treatment at a reception prison in New South Wales, Australia
12:55 PM - 1:00 PMBiography
Tracey has worked with people who use drugs for over 35 years for NSW Health, Australia. She is currently the Program Manager, HIV and Related programs for Justice Health NSW working with people who are incarcerated. She is passionate about working with peers and people with lived or living experience to help progress towards hepatitis C elimination.
Dr. Marion Selfridge
Research Manager
Cool Aid Community Health Centre
Three ways to test: creating flexibility in a peer outreach hepatitis C (HCV) point-of-care testing program in Victoria, British Columbia
1:00 PM - 1:05 PMBiography
Marion Selfridge is a research manager, focusing on HIV and Hepatitis C treatment at the Cool Aid Community Health Centre and research associate at UVic’s Canadian Institute of Substance Use Research. Her PhD dissertation research focused on street-involved youths’ use of social media to deal with grief and loss. She teaches dance to stay sane.
Ms Olivia Dawson
Programs and Policy Manager
INHSU
Applying implementation science to scale hepatitis C models of care: the INHSU HCV intervention symposium series
1:05 PM - 1:10 PMBiography
Olivia Dawson works as the Programs and Policy Manager for INHSU. With a strong track record in the development and delivery of training, education and capacity strengthening programs in hepatitis C, she has driven impactful health education initiatives across Europe and North America since 2017. Olivia has collaborated with governments, NGOs, and affected communities to implement innovative programs addressing viral hepatitis and harm reduction. She has contributed to high-level UN forums on SDG implementation including the Commission for Social Development. Olivia's multilingual proficiency and commitment to social justice underscore her desire to advance global health equity.
INHSU 2026
Session Q&A
1:10 PM - 1:15 PMBiography